id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-N-0096-0004,FDA,FDA-2003-N-0096,"Draft Guidance for Industry: Manufacturing Biological Drug Substances, Intermediates, or Products Using Spore-Forming Microorganisms; Availability",Notice,Notice of Data Availability,2005-03-03T05:00:00Z,2005,3,2005-02-24T05:00:00Z,2005-05-26T03:59:59Z,2025-06-18T19:26:25Z,05-3593,0,0,090000648048390b
FDA-2003-N-0096-0003,FDA,FDA-2003-N-0096,"Guidance for Industry; Manufacturing Biological Drug Substances, Intermediates, or Products Using Spore-Forming Microorganisms; Draft Guidance",Supporting & Related Material,Background Material,2005-03-03T05:00:00Z,2005,3,,,2025-06-18T19:48:43Z,,0,0,0900006480483907